Congestive heart failure is the leading cause of death in patients with end-stage renal disease. The process of this type of dysfunction is termed uremic cardiomyopathy. Extensive myocardial fibrosis, which leads the process, has also been shown to be a stronger predictor of death. Recently, anti-fibrosis has risen as a hot target in the treatment of uremic cardiomyopathy. Therefore, its urgent to find a more accurate and non-invasive method in order to meet the demand of clinic.In this study, we use the native T1 mapping to assess the level of myocardial fibrosis in ESRD patients，comparing with the Coronary Artery Calcium Score, in order to evaluate its accuracy in diagnosis uremic cardiomyopathy.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords